This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Intensive Care Unit Acquired Paresis or Muscle Wasting
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The primary hypothesis for this study is that Myostatin and FHL-1 are important in the development of ICUAP and that changes in activity levels of muscle will modify the levels of expression and activity of these proteins.

Provided treatments

  • Other: Active muscle stimulation

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01321320. The sponsor of the trial is Imperial College London and it is looking for 13 volunteers for the current phase.
Official trial title:
Investigation of the Role of FHL-1 and Myostatin in the Development of Intensive Care Unit Acquired Paresis (ICUAP) and the Effect of Increased Muscle Activity on These Pathways.